持続可能な医薬品包装の世界市場 - 2024年～2032年

持続可能な医薬品包装の世界市場は2024年に919億4,000万米ドルに達し、2032年には2,729億8,000万米ドルに達すると予測され、予測期間2024年のCAGRは12.7%で成長します。

持続可能な医薬品包装は、廃棄物を減らし、二酸化炭素排出量を減らし、リサイクルや生分解性を促進する材料や設計を包含します。製薬業界が消費者、規制当局、環境団体から、より持続可能な慣行を採用するよう圧力に直面しているため、このアプローチはますます重要になっています。持続可能な包装は、製薬業界の環境負荷低減に役立つだけでなく、世界の持続可能性の目標にも合致します。

市場力学：

促進要因と阻害要因

リサイクル可能で環境に優しい素材に対する消費者の嗜好の高まり

リサイクル可能で環境に優しい素材に対する消費者の嗜好は、持続可能な医薬品包装市場にますます影響を与えています。環境への関心が高まるにつれ、消費者は包装廃棄物が地球に及ぼす悪影響についてより強く認識するようになっています。このような消費者の意識は、製薬会社が持続可能な慣行を採用し、リサイクル可能、生分解性、または再生可能な資源から作られた包装を優先させるよう提唱することを促しています。その結果、このような消費者行動の変化により、メーカーは環境意識の高い消費者の価値観に合わせ、環境に優しい素材を革新的に製品設計に取り入れる必要に迫られています。

メーカー各社は、有害なプラスチックやその他の素材が環境に与える影響を減らすため、革新的で持続可能なソリューションを開発しています。例えば、バイエルは2024年10月30日、ヘルスケア業界初となるポリエチレンテレフタレート（PET）製ブリスター包装を同社の有名ブランドであるアレベに採用しました。

環境に優しい包装への需要の高まりは、製薬業界における研究開発への大きな投資を促しています。企業は従来のプラスチックに代わる素材を模索しており、ガラス、紙、生分解性ポリマーなどを選択しています。例えば、2023年11月7日、ACGは新しい持続可能な包装技術を発表しました。これらのイノベーションは、製薬セクターにおける環境責任と業務効率を高めるために設計されています。これらの環境に優しいパッケージングソリューションのイントロダクションは、ACGの持続可能性とイノベーションへのコミットメントを大きく前進させるものです。

環境に優しい素材に伴う高いコスト

持続可能なパッケージングソリューションは、多くの場合、高度な技術、特殊な材料、独自の製造工程を必要とするため、製造コストが大幅に上昇する可能性があります。厳しい利益率で運営されている製薬会社にとって、こうした追加費用は大きな課題となります。さらに、生分解性プラスチックや再生可能資源など、特定の環境に優しい素材に関連する価格変動は、市場での幅広い採用を妨げる可能性のある財政的不安定性を引き起こします。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • リサイクル可能で環境に優しい素材に対する消費者の嗜好の高まり
  • 抑制要因
    • 環境に優しい材料に関連する高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 パッケージングタイプ別

• 一次包装
• 二次包装

第7章 プロセス別

• リサイクル可能
• 再利用可能
• 生分解性

第8章 原材料別

• 紙・板紙
• ガラス
• バイオプラスチック
• 金属
• その他

第9章 製品タイプ別

• ブリスター包装
• ラベルとアクセサリー
• キャップとクロージャー
• プレフィルド吸入器
• バイアル
• プレフィルドシリンジ
• アンプル
• カートリッジ
• その他

第10章 原材料別

• 紙・板紙
• ガラス
• バイオプラスチック
• 金属
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第12章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第13章 企業プロファイル

• Amcor plc
• Berry Global Inc.
• Gerresheimer AG
• WestRock Company
• Drug Plastics & Glass Co., Inc.
• CCL Healthcare
• Comar
• Bormioli Pharma S.p.A.
• Origin Pharma Packaging
• Ascend Packaging Systems LLC.

第14章 付録

The global Sustainable Pharmaceutical Packaging market reached US$ 91.94 billion in 2024 and is expected to reach US$ 272.98 billion by 2032, growing at a CAGR of 12.7% during the forecast period 2024-2032.

Sustainable pharmaceutical packaging encompasses materials and designs that reduce waste, lower carbon emissions, and promote recycling or biodegradability. This approach is increasingly important as the pharmaceutical industry faces pressure from consumers, regulators, and environmental organizations to adopt more sustainable practices. Sustainable packaging not only helps in reducing the industry's environmental impact but also aligns with global sustainability goals.

Market Dynamics: Drivers & Restraints

Rising consumer preference for recyclable and eco-friendly materials

Consumer preference for recyclable and eco-friendly materials is increasingly influencing the sustainable pharmaceutical packaging market. As environmental concerns rise, consumers are becoming more aware of the detrimental effects of packaging waste on the planet. This awareness is prompting them to advocate for pharmaceutical companies to adopt sustainable practices, prioritizing packaging made from recyclable, biodegradable, or renewable resources. Consequently, this shift in consumer behavior is compelling manufacturers to innovate and integrate eco-friendly materials into their product designs, aligning with the values of environmentally conscious consumers.

Manufacturers are developing innovative sustainable solutions to reduce the impact of harmful plastic and other materials on the environment. For instance, on October 30, 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve.

The growing demand for eco-friendly packaging is driving significant investments in research and development within the pharmaceutical industry. Companies are exploring alternatives to traditional plastics, opting for materials such as glass, paper, and biodegradable polymers. For instance, on November 07, 2023, ACG launched its new sustainable packaging technologies. These innovations are designed to enhance environmental responsibility and operational efficiency within the pharmaceutical sector. The introduction of these eco-friendly packaging solutions marks a significant step forward in ACG's commitment to sustainability and innovation.

High costs associated with eco-friendly materials

Sustainable packaging solutions often require advanced technologies, specialized materials, and unique production processes, which can lead to significantly higher manufacturing costs. For pharmaceutical companies that operate on tight profit margins, these additional expenses can present a considerable challenge. Furthermore, the price fluctuations associated with certain eco-friendly materials, such as biodegradable plastics and renewable resources cause financial instability that could hinder their broader adoption in the market.

Segment Analysis

The global sustainable pharmaceutical packaging market is segmented based on packaging type, process, raw material, product type, end-user, and region.

Type:

Recyclable segment is expected to dominate the global sustainable pharmaceutical packaging market share

Recyclable sustainable pharmaceutical packaging is anticipated to dominate the market due to its increasing popularity among consumers, regulatory pressures, and cost-effectiveness. As awareness of environmental concerns continues to grow globally, consumers are seeking packaging solutions that minimize waste and support sustainability.

Recyclable packaging offers a practical, eco-friendly option, allowing pharmaceutical companies to meet consumer demands while reducing their environmental impact. The ability to recycle materials not only helps reduce waste sent to landfills but also supports the circular economy, where resources are reused, making recyclable packaging a preferred solution.

Additionally, the rising initiatives to recycle pharmaceutical wastes and packaging solutions are encouraging the adoption of recyclable packaging solutions in the pharmaceutical industries. For instance, on April 29, 2024, the United Kingdom launched The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative to develop and implement strategies for the end-of-use recycling of medicinal devices and pharmaceutical packaging.

Moreover, governments worldwide are implementing stricter packaging waste regulations, encouraging companies to shift towards recyclable materials. In response, pharmaceutical manufacturers are adopting recyclable packaging to comply with these policies and avoid potential penalties. Advancements in recycling technology are also enhancing the efficiency and practicality of recycling processes, making recyclable packaging more affordable and viable. This combination of consumer demand, regulatory incentives, and technological improvements is driving recyclable packaging to become a dominant force in the sustainable pharmaceutical packaging market.

Geographical Analysis

North America is expected to hold a significant position in the global sustainable pharmaceutical packaging market share

North America is expected to lead the sustainable pharmaceutical packaging market due to a variety of factors, such as growing consumer demand for eco-friendly products, stricter government regulations, and the presence of major industry players. Consumers in the region are increasingly concerned about environmental issues like climate change and plastic pollution, which has led to a rising demand for more sustainable packaging options.

In response, pharmaceutical companies in North America are focusing on adopting eco-friendly packaging solutions to meet these consumer expectations. This shift is further supported by a collective effort from both consumers and businesses to reduce waste and lessen their environmental impact, making North America a leader in sustainable packaging adoption.

In addition, government policies in North America are playing a significant role in driving the growth of sustainable pharmaceutical packaging. Both the U.S. and Canadian governments have introduced more stringent regulations on environmental practices and packaging waste management, motivating pharmaceutical companies to explore greener alternatives.

North America has several pharmaceutical manufacturers and packaging providers who are investing in new technologies and research to create innovative, sustainable packaging materials. For instance, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements, and OTC treatments.

This combination of industry collaboration, favorable economic conditions, and access to advanced technologies positions North America as a key driver in the global market for sustainable pharmaceutical packaging.

Asia Pacific is growing at the fastest pace in the global Sustainable Pharmaceutical Packaging market

The Asia Pacific region is experiencing the fastest growth in the global sustainable pharmaceutical packaging market due to several factors, including rapid industrial development, increasing consumer awareness, and evolving government regulations. As pharmaceutical industries in countries like China and India continue to expand, there is an increasing demand for packaging solutions that meet sustainability objectives. This shift is largely driven by a growing, environmentally conscious middle class, which is encouraging companies to embrace eco-friendly packaging alternatives.

The rising concerns about plastic waste and environmental impact in the region are prompting both consumers and businesses to prioritize sustainable packaging options, fueling the growth of the sustainable pharmaceutical packaging sector. The market players in the region are expanding their production of sustainable pharmaceutical packaging solutions which is also contributing to the region's market growth. For instance, on 6 November 2023, Amcor launched the next generation of its Medical Laminates solutions. Amcor's latest innovation enables the development of all-film packaging that is recyclable in the polyethylene stream. The new solution reduces the carbon footprint of the final package while maintaining the performance requirements of device applications, helping medical companies to progress their sustainability goals without compromising patient safety.

Competitive Landscape

The major global players in the sustainable pharmaceutical packaging market include Amcor plc, Berry Global Inc., Gerresheimer AG, WestRock Company, Drug Plastics & Glass Co., Inc., CCL Healthcare, Comar, Bormioli Pharma S.p.A., Origin Pharma Packaging and Ascend Packaging Systems LLC. among others.

Key Developments

• In July 2024, Aluflexpack announced the development of a new product: the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging.
• April 2022, Amcor announced the addition of new, more sustainable High Shield laminates to its pharmaceutical packaging portfolio. The new low-carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies' recyclability agendas.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global sustainable pharmaceutical packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Packaging Type
• 3.2. Snippet by Process
• 3.3. Snippet by Raw Material
• 3.4. Snippet by Product Type
• 3.5. Snippet by End-User
• 3.6. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising consumer preference for recyclable and eco-friendly materials
  • 4.1.2. Restraints
    • 4.1.2.1. High costs associated with eco-friendly materials
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Packaging Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 6.1.2. Market Attractiveness Index, By Packaging Type
• 6.2. Primary Packaging*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Secondary Packaging

7. By Process

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 7.1.2. Market Attractiveness Index, By Process
• 7.2. Recyclable*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Reusable
• 7.4. Biodegradable

8. By Raw Material

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 8.1.2. Market Attractiveness Index, By Raw Material
• 8.2. Paper & Paperboard*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Glass
• 8.4. Bioplastics
• 8.5. Metal
• 8.6. Others

9. By Product Type

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.1.2. Market Attractiveness Index, By Product Type
• 9.2. Blisters*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Labels & Accessories
• 9.4. Caps & Closures
• 9.5. Pre-filled Inhalers
• 9.6. Vials
• 9.7. Pre-filled Syringes
• 9.8. Ampoules
• 9.9. Cartridges
• 9.10. Others

10. By Raw Material

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 10.1.2. Market Attractiveness Index, By Raw Material
• 10.2. Paper & Paperboard*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Glass
• 10.4. Bioplastics
• 10.5. Metal
• 10.6. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.8.1. U.S.
    • 11.2.8.2. Canada
    • 11.2.8.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.8.1. Germany
    • 11.3.8.2. U.K.
    • 11.3.8.3. France
    • 11.3.8.4. Spain
    • 11.3.8.5. Italy
    • 11.3.8.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.8.1. Brazil
    • 11.4.8.2. Argentina
    • 11.4.8.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.8.1. China
    • 11.5.8.2. India
    • 11.5.8.3. Japan
    • 11.5.8.4. South Korea
    • 11.5.8.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Amcor plc*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Berry Global Inc.
• 13.3. Gerresheimer AG
• 13.4. WestRock Company
• 13.5. Drug Plastics & Glass Co., Inc.
• 13.6. CCL Healthcare
• 13.7. Comar
• 13.8. Bormioli Pharma S.p.A.
• 13.9. Origin Pharma Packaging
• 13.10. Ascend Packaging Systems LLC.

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us